Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy. [electronic resource]
Producer: 20160802Description: 473159 p. digitalISSN:- 2314-6141
- AC133 Antigen
- Animals
- Antigens, CD -- metabolism
- Bone Marrow Cells -- cytology
- Bone Marrow Transplantation -- standards
- Cardiomyopathies -- etiology
- Device Approval -- standards
- Europe
- Glycoproteins -- metabolism
- Guideline Adherence
- Humans
- Myocardial Ischemia -- complications
- Peptides -- metabolism
- Practice Guidelines as Topic
- Stem Cell Transplantation -- standards
- Stem Cells
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.